Macrolides
Ohtami, H.; Nakase, A.; Kawai, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 2): 744-749
2003
ISSN/ISBN: 0047-1852 PMID: 12722310 Document Number: 564386
Document emailed within 1 workday
Related Documents
Rolin, O.; Bouanchaud, D.H. 1989: Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus Pathologie-Biologie 37(5): 375-377Samsygina, G.A. 1999: Macrolides and phagocytosis Antibiotiki i Khimioterapiia 44(2): 33-36
Endou, K.; Nakajima, Y. 1997: Resistance to macrolides Nihon Rinsho. Japanese Journal of Clinical Medicine 55(5): 1238-1244
De Marino, V.; Marino, A. 1988: Macrolides: a critical re-evaluation La Clinica Terapeutica 127(2): 91-98
Mensa, J.é; García-Vázquez, E.; Vila, J. 2003: Macrolides, ketolides and streptogramins Enfermedades Infecciosas y Microbiologia Clinica 21(4): 200-207; Quiz 208, 219
Oishi, K. 2000: Tracheal neutrophils and macrolides Japanese Journal of Antibiotics 53 Suppl A: 99-102
Guo, D.; Cai, Y.; Chai, D.; Liang, B.; Bai, N.; Wang, R. 2010: The cardiotoxicity of macrolides: a systematic review Die Pharmazie 65(9): 631-640
Shafran, S.D.; Conley, J.M. 1997: Does Chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides? Canadian Journal of Cardiology 13(11): 1017-1019
2003: Telithromycin: new preparation. A needless addition to the other macrolides Prescrire International 12(63): 8-11
Millesimo, M.; Savoia, D. 1995: Group A streptococci: evaluation of in vitro resistance to two macrolides Microbios 82(332): 141-147
Bochet, M.él.; Garin, N.; Janssens, J.-P.; Gerstel, E. 2011: Is there a role for prophylactic antibiotic treatment with macrolides in bronchiectasis? Revue Medicale Suisse 7(280): 308; 310-312
Kyo, S.; Tamaoki, J.; Kondo, M.; Isono, K.; Nagai, A. 1998: Effects of macrolides on intracellular Ca2+ response by airway epithelium Japanese Journal of Antibiotics 51 Suppl A: 155-157
Khrianin, A.A.; Reshetnikov, O.V. 2010: Use of macrolides in pregnancy and lactation according to evidence-based medicine: pro et contra Antibiotiki i Khimioterapiia 55(9-10): 50-56
Płusa, T. 2008: Clinical basis of macrolides apply in diseases of the respiratory tract Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 25(149): 432-436
Lin, J.T.; Zhang, Y.M.; Zhou, X.; Wang, C.Z.; Huang, M.; Liu, C.T.; Wu, C.G.; Wan, H.Y.; Yu, W.C.; Dai, Y.R. 2017: Chinese expert consensus for non-antiinfective effects and clinical use of macrolides Zhonghua Nei Ke Za Zhi 56(7): 546-557
Alonso Manzanares, M.A.; Gutíerrez Zufiaurre, M.N.; Muñoz Bellido, J.L.; García-Rodríguez, J.A. 1998: Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae Medicina Clinica 110 Suppl. 1: 25-30
Mégraud, F.; Occhialini, A.; Doermann, H.P. 1997: Resistance of Helicobacter pylori to macrolides and nitroimidazole compounds. the current situation Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 48(Suppl 4): 25-38
Hirano, M.; Miwa, M.; Saito, S.; Baba, R.; Takasu, A.; Iwata, S.; Hazama, A.; Okada, Y. 1998: Effects of macrolides on electrolyte secretion by airway ciliary epithelial cells Japanese Journal of Antibiotics 51 Suppl A: 152-154
Yamaya, M.; Suzuki, T.; Asada, M.; Sasaki, T.; Nishimura, H. 2007: New findings on the biological activities of macrolides--antiviral effects of macrolide antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl 2(Part 1): 679-682
Dumont, F.J.; Staruch, M.J.; Koprak, S.L.; Melino, M.R.; Sigal, N.H. 1990: Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin Journal of Immunology 144(1): 251-258